To explore the mechanism by which PRMT5 regulates splicing in BCSCs, we focused on the RNA-binding protein SRSF1 because of its association with breast cancer, its ability to regulate cisplatin sensitivity, and that PRMT5-dependent methylation regulates splicing in AML cells [41, 45–47]. Here, SRSF1 is linked to breast cancer.